DES in Bifurcation Lesions insight from the ICPS Registry
European Bifurcation Club 2007, EBC 2007 – Valencia, Spain
NEW DEVICES, NEW TECHNIQUES
DES in Bifurcation Lesions insight from the ICPS Registry
Author: Thierry Lefevre, MD, ICPS, France
STUDY
- Prospective registry (2003-2005)
- All consecutive DES patients
- Provisonal SB T-stenting strategy
- Clinical follow-up at 6, 12 months and 2 years
- Angiography in case of ischaemia
- Aspirin ≥75 mg/d, indefinitely
- Clopidogrel 75 to 150 mg/d > 2/6 months (Cypher/Taxus)
CONCLUSION
In this large real world prospective multicenter study on bifurcation lesions stenting using a predefined strategy of provisional SB T-stenting, we found that this approach can be used in about90% of cases. We found very promising results up to 2 years.
The risk of stent thrombosis remains acceptablecompared to non bifurcation lesions. The only independant procedural predictor of death is the non use of a provisional SB T-stenting strategy. However, there is probably confounding factors.